Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
DirectorOfficer
Latest Insider Transactions
Showing 10 of 35 transactions (past 365 days)
| 2026-05-26 | 2026-05-22 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale | 10,926 | $26.78 | $292,642 |
| 2026-05-26 | 2026-05-21 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Exercise Conversion | 23,250 | $0.00 | $0 |
| 2026-05-19 | 2026-05-18 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale | 1,129 | $26.76 | $30,212 |
| 2026-05-19 | 2026-05-17 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Exercise Conversion | 2,419 | $0.00 | $0 |
| 2026-05-13 | 2026-05-12 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale | 3,322 | $26.71 | $88,731 |
| 2026-05-13 | 2026-05-11 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Exercise Conversion | 7,120 | $0.00 | $0 |
| 2026-04-20 | 2026-04-17 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale | 9,550 | $20.22 | $193,063 |
| 2026-04-20 | 2026-04-16 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Exercise Conversion | 20,312 | $0.00 | $0 |
| 2026-03-10 | 2026-03-09 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sale | 6,693 | $16.08 | $107,630 |
| 2026-03-10 | 2026-03-06 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Exercise Conversion | 15,625 | $0.00 | $0 |
KALV
CEO
Sale
$292.6K
10,926 shares @ $26.78
Filed 2026-05-26Trade 2026-05-22
Kalvista Pharmaceuticals, Inc.KALV
CEO
Exercise Conversion
$0
23,250 shares @ $0.00
Filed 2026-05-26Trade 2026-05-21
Kalvista Pharmaceuticals, Inc.KALV
CEO
Sale
$30.2K
1,129 shares @ $26.76
Filed 2026-05-19Trade 2026-05-18
Kalvista Pharmaceuticals, Inc.KALV
CEO
Exercise Conversion
$0
2,419 shares @ $0.00
Filed 2026-05-19Trade 2026-05-17
Kalvista Pharmaceuticals, Inc.KALV
CEO
Sale
$88.7K
3,322 shares @ $26.71
Filed 2026-05-13Trade 2026-05-12
Kalvista Pharmaceuticals, Inc.KALV
CEO
Exercise Conversion
$0
7,120 shares @ $0.00
Filed 2026-05-13Trade 2026-05-11
Kalvista Pharmaceuticals, Inc.KALV
CEO
Sale
$193.1K
9,550 shares @ $20.22
Filed 2026-04-20Trade 2026-04-17
Kalvista Pharmaceuticals, Inc.KALV
CEO
Exercise Conversion
$0
20,312 shares @ $0.00
Filed 2026-04-20Trade 2026-04-16
Kalvista Pharmaceuticals, Inc.KALV
CEO
Sale
$107.6K
6,693 shares @ $16.08
Filed 2026-03-10Trade 2026-03-09
Kalvista Pharmaceuticals, Inc.KALV
CEO
Exercise Conversion
$0
15,625 shares @ $0.00
Filed 2026-03-10Trade 2026-03-06
Kalvista Pharmaceuticals, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.